- Home
- NERV vs KRKR Comparison
NERV vs KRKR Comparison
Compare NERV & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- KRKR
- Stock Information
- Founded
- NERV 2007
- KRKR 2010
- Country
- NERV United States
- KRKR China
- Employees
- NERV N/A
- KRKR N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- KRKR Business Services
- Sector
- NERV Health Care
- KRKR Consumer Discretionary
- Exchange
- NERV Nasdaq
- KRKR Nasdaq
- Market Cap
- NERV 10.7M
- KRKR 9.1M
- IPO Year
- NERV 2014
- KRKR 2019
- Fundamental
- Price
- NERV $1.61
- KRKR $4.10
- Analyst Decision
- NERV Hold
- KRKR
- Analyst Count
- NERV 1
- KRKR 0
- Target Price
- NERV $5.00
- KRKR N/A
- AVG Volume (30 Days)
- NERV 15.1K
- KRKR 19.8K
- Earning Date
- NERV 04-30-2025
- KRKR 03-11-2025
- Dividend Yield
- NERV N/A
- KRKR N/A
- EPS Growth
- NERV N/A
- KRKR N/A
- EPS
- NERV 0.19
- KRKR N/A
- Revenue
- NERV N/A
- KRKR $31,657,328.00
- Revenue This Year
- NERV N/A
- KRKR $182.55
- Revenue Next Year
- NERV N/A
- KRKR N/A
- P/E Ratio
- NERV $8.95
- KRKR N/A
- Revenue Growth
- NERV N/A
- KRKR N/A
- 52 Week Low
- NERV $1.42
- KRKR $2.76
- 52 Week High
- NERV $3.69
- KRKR $12.99
- Technical
- Relative Strength Index (RSI)
- NERV 41.00
- KRKR 49.02
- Support Level
- NERV $1.54
- KRKR $3.93
- Resistance Level
- NERV $1.89
- KRKR $4.26
- Average True Range (ATR)
- NERV 0.11
- KRKR 0.22
- MACD
- NERV 0.00
- KRKR 0.03
- Stochastic Oscillator
- NERV 22.68
- KRKR 42.83
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.